Denka Company (4061) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
6 Feb, 2026Executive summary
Operating income for 3Q FY2025 rose to ¥18.2 billion, up 54.0% year-over-year, driven by demand recovery in semiconductors and the impact of DPE production suspension.
Net income reached ¥5.5 billion, a 114.7% increase year-over-year, aided by gains from land sales despite extraordinary DPE-related losses.
Net sales for the nine months ended December 31, 2025, were ¥290.8 billion, a 3.6% decrease year-over-year, mainly due to lower sales prices following declines in raw material and fuel costs.
Comprehensive income for the period was ¥5,143 million, up from ¥4,203 million in the prior year.
Financial highlights
3Q FY2025 sales were ¥290.8 billion, down ¥10.8 billion year-over-year; operating margin improved to 6.3% from 3.9%.
Ordinary income increased to ¥13.7 billion (+¥9.4 billion YoY); extraordinary losses of ¥13.5 billion mainly from DPE shutdown, offset by ¥8.2 billion gain on land sale.
Gross profit increased to ¥69,744 million from ¥64,979 million year-over-year.
Basic earnings per share for the nine months was ¥64.23, up from ¥29.92 year-over-year.
Total assets at December 31, 2025, were ¥655,195 million, with net assets of ¥312,568 million and an equity ratio of 45.2%.
Outlook and guidance
Full-year sales forecast revised to ¥390.0 billion (down ¥10.3 billion from previous), but operating and net income forecasts unchanged at ¥25.0 billion and ¥15.0 billion, respectively.
Basic earnings per share for the full year projected at ¥174.06.
Dividend forecast maintained at ¥100 per share, targeting a 57% total return ratio.
Management aims to maintain or increase dividends, with a long-term total return ratio goal of 50% over eight years.
Segment forecasts adjusted: Life Innovation and Elastomers & Infrastructure Solutions revised downward, while Electronics & Innovative Products and Polymer Solutions revised upward.
Latest events from Denka Company
- Net income surged on asset sales despite lower sales, operating income, and DPE suspension.4061
Q1 202617 Mar 2026 - Mission 2030 Phase 2 targets record earnings, portfolio transformation, and sustainability.4061
Investor presentation27 Feb 2026 - Net sales rose but profits fell; full-year growth and stable dividends are forecast.4061
Q2 20257 Jan 2026 - Profits rose in 1H FY2025, with stable profit guidance and DPE losses offset by asset sales.4061
Q2 202610 Nov 2025 - Strong profit growth continues, but US regulatory risks for chloroprene rubber remain.4061
Q1 202513 Jun 2025 - Profit rebound is forecast after a net loss from extraordinary DPE-related losses.4061
Q4 20256 Jun 2025 - Sales up, profits down; forecasts and dividend unchanged amid regulatory risks.4061
Q3 20255 Jun 2025